STELLARIS PHARMACEUTICALS ApS: Financial statements 2016
CVR: 34708215
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -117,646 compared with DKK -127,288 the year before. Equity in the 2016 report amounted to DKK -575,121.
- Profit/Loss
- DKK -117,646
- Equity
- DKK -575,121
- Total Assets
- DKK 67,862
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -118 t. | -575 t. | - |
| 2015 | - | - | -127 t. | -457 t. | - |
| 2014 | - | - | -384 t. | -330 t. | - |
Official annual report
Find more companies like STELLARIS PHARMACEUTICALS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2015. The net result was DKK -127,288.
As of February 16, 2016, Ranoda Holding ApS is registered as an owner of STELLARIS PHARMACEUTICALS ApS with an ownership share of 100%.
As of February 11, 2016, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of STELLARIS PHARMACEUTICALS ApS.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.